Page last updated: 2024-08-24

rp 59227 and Asthma, Bronchial

rp 59227 has been researched along with Asthma, Bronchial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bewtra, AK; Eda, R; Gillen, MS; Hopp, RJ; Townley, RG	1

Trials

1 trial(s) available for rp 59227 and Asthma, Bronchial

Article	Year
The effect of RP 59227, a platelet-activating factor antagonist, against antigen challenge and eosinophil and neutrophil chemotaxis in asthmatics. Journal of lipid mediators and cell signalling, 1994, Volume: 10, Issue:3 Topics: Administration, Oral; Adult; Antigens; Asthma; Chemotaxis, Leukocyte; Cross-Over Studies; Double-Blind Method; Eosinophils; Humans; Male; Neutrophils; Platelet Activating Factor; Pyridines; Skin Tests; Thiazoles	1994

Article

Year

The effect of RP 59227, a platelet-activating factor antagonist, against antigen challenge and eosinophil and neutrophil chemotaxis in asthmatics.

Journal of lipid mediators and cell signalling, 1994, Volume: 10, Issue:3

Topics: Administration, Oral; Adult; Antigens; Asthma; Chemotaxis, Leukocyte; Cross-Over Studies; Double-Blind Method; Eosinophils; Humans; Male; Neutrophils; Platelet Activating Factor; Pyridines; Skin Tests; Thiazoles

1994